Given abundant evidence implicating heparanase in PDAC pathogenesis/aggressiveness/therapy resistance (13–17, 25), our finding may provide a partial explanation for the mechanism through which diabetic state contributes to pancreatic carcinoma progression. This evidence concerns the gene HPSE and exocrine pancreatic carcinoma.